Otitis media with effusion (serous otitis media) in children: Management Authors

Authors Jerome O Klein, MD Stephen Pelton, MD Section Editors Sheldon L Kaplan, MD Ellen M Friedman, MD Deputy Editor Mary M Torchia, MD Disclosures: Jerome O Klein, MD Consultant/Advisory Boards: GlaxoSmithKline [Vaccines (Pneumococcal)]; Cubist [Antibiotic for Clostridium difficile (Fidaxomicin)]. Stephen Pelton, MD Grant/Research/Clinical Trial Support: Pfizer [pneumococcal disease surveillance (PCV13)]; Merck [NP surveillance for pneumococcal carriage ( PCV15)]; Cempra [Efficacy of Solithromycin in experimental Otitis Media (macrolide)]; Windhoek health care [New formulation of Amox/clar (amoxicillin, clarithromycin). Consultant/Advisory Boards: Pfizer [pneumococcal disease (PCV13)]; GSK bio [pneumococcal disease (PCV10)]. Sheldon L Kaplan, MD Grant/Research/Clinical Trial Support: Pfizer [Pneumococcal surveillance studies (PCV13)]; Cubist [S. aureus skin and soft tissue infections (daptomycin pediatric studies)]; Optimer [fidaxomicin pediatric studies]; Cerexa [ceftaroline Pediatric studies]. Consultant/Advisory Boards: Pfizer [Pneumococcal surveillance studies (PCV13)]. Ellen M Friedman, MD Nothing to disclose. Mary M Torchia, MD Employee of UpToDate, Inc.